{"transactions":[{"id":1758215,"issuer":{"id":6920,"kind":"organization","name":"CVRx, Inc."},"owners":[{"id":108916,"kind":"person","name":"Galle Liz","position":1,"cik":"0001869353","reported_name":"Galle Liz","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP OF GLOBAL CLINICAL RESEARCH"}}],"security":"Stock Option (right to buy)","published_at":"2023-10-18T16:51:31.000Z","date":"2023-10-16","kind":"exercise","planned":false,"acquired":false,"shares":778,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Fully vested."}],"balance_after":0,"derivative":{"exercise_price":0.237,"expiration_date":"2023-11-11","underlying":"Common Stock","underlying_shares":778},"source":{"system":"sec-edgar","filing":"0001415889-23-014406","document":"form4-10182023_081024.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1869353/000141588923014406/form4-10182023_081024.xml","form_type":"4"}},{"id":1758214,"issuer":{"id":6920,"kind":"organization","name":"CVRx, Inc."},"owners":[{"id":108916,"kind":"person","name":"Galle Liz","position":1,"cik":"0001869353","reported_name":"Galle Liz","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP OF GLOBAL CLINICAL RESEARCH"}}],"security":"Common Stock","published_at":"2023-10-18T16:51:31.000Z","date":"2023-10-16","kind":"exercise","planned":false,"acquired":true,"shares":778,"price":0.237,"value":184.386,"ownership":{"direct":true},"balance_after":778,"source":{"system":"sec-edgar","filing":"0001415889-23-014406","document":"form4-10182023_081024.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1869353/000141588923014406/form4-10182023_081024.xml","form_type":"4"}},{"id":2049859,"issuer":{"id":6920,"kind":"organization","name":"CVRx, Inc."},"owners":[{"id":108916,"kind":"person","name":"Galle Liz","position":1,"cik":"0001869353","reported_name":"Galle Liz","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP OF GLOBAL CLINICAL RESEARCH"}}],"security":"Stock Option (right to buy)","published_at":"2023-01-20T19:14:09.000Z","date":"2023-01-18","kind":"grant","acquired":true,"shares":26000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vests as to 25% of the shares on January 18, 2024 and as to 1/48th of the shares each month thereafter."}],"balance_after":26000,"derivative":{"exercise_price":15.22,"expiration_date":"2033-01-17","underlying":"Common Stock","underlying_shares":26000},"source":{"system":"sec-edgar","filing":"0001415889-23-001287","document":"form4-01212023_120100.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1869353/000141588923001287/form4-01212023_120100.xml","form_type":"4"}},{"id":2194646,"issuer":{"id":6920,"kind":"organization","name":"CVRx, Inc."},"owners":[{"id":108916,"kind":"person","name":"Galle Liz","position":1,"cik":"0001869353","reported_name":"Galle Liz","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP OF GLOBAL CLINICAL RESEARCH"}}],"security":"Stock Option (right to buy)","published_at":"2022-08-04T20:25:28.000Z","date":"2022-08-02","kind":"grant","acquired":true,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vests as to 25% of the shares on August 2, 2023 and as to 1/48th of the shares each month thereafter."}],"balance_after":8000,"derivative":{"exercise_price":9.01,"expiration_date":"2032-08-01","underlying":"Common Stock","underlying_shares":8000},"source":{"system":"sec-edgar","filing":"0001415889-22-008287","document":"form4-08042022_050857.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1869353/000141588922008287/form4-08042022_050857.xml","form_type":"4"}},{"id":2430889,"issuer":{"id":6920,"kind":"organization","name":"CVRx, Inc."},"owners":[{"id":108916,"kind":"person","name":"Galle Liz","position":1,"cik":"0001869353","reported_name":"Galle Liz","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of Global Clinical Research"}}],"security":"Stock Option (right to buy)","published_at":"2022-01-20T18:14:28.000Z","date":"2022-01-18","kind":"grant","acquired":true,"shares":25900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vests as to 25% of the shares on January 18, 2023 and as to 1/48th of the shares each month thereafter."}],"balance_after":25900,"derivative":{"exercise_price":9.08,"expiration_date":"2032-01-17","underlying":"Common Stock","underlying_shares":25900},"source":{"system":"sec-edgar","filing":"0001179110-22-000545","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1869353/000117911022000545/edgar.xml","form_type":"4"}},{"id":2648105,"issuer":{"id":6920,"kind":"organization","name":"CVRx, Inc."},"owners":[{"id":108916,"kind":"person","name":"Galle Liz","position":1,"cik":"0001869353","reported_name":"Galle Liz","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of Global Clinical Research"}}],"security":"Stock Option (right to buy)","published_at":"2021-07-01T17:28:45.000Z","date":"2021-06-29","kind":"grant","acquired":true,"shares":19700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vests as to 25% of the shares on June 29, 2022 and as to 1/48th of the shares each month thereafter."}],"balance_after":19700,"derivative":{"exercise_price":18,"expiration_date":"2031-06-28","underlying":"Common Stock","underlying_shares":19700},"source":{"system":"sec-edgar","filing":"0001179110-21-007265","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1869353/000117911021007265/edgar.xml","form_type":"4"}}]}